Schroder Investment Management has filed a substantial acquisition disclosure with stock exchanges following a reduction in its shareholding in Apollo Hospitals Enterprise Ltd. The disclosure, made under Regulation 29(2) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations 2011, details a significant stake reduction through open market transactions.

Transaction Details

The investment management firm sold 206,610 shares of Apollo Hospitals Enterprise Ltd on 21 January 2026 through open market transactions. This disposal reduced Schroder's percentage holding by 0.14% of the company's total share capital.

Shareholding Position

Following the transaction, Schroder Investment Management's total shareholding in Apollo Hospitals has been adjusted as detailed below:

Acquirer Information

The disclosure identifies Schroder Investment Management (Singapore) Ltd and Schroder Investment Management (Hong Kong) Ltd as the primary acquirers, operating as discretionary fund managers of funds and segregated mandates. The broader Schroders Group is listed as persons acting in concert, also functioning as discretionary fund managers.

Key details about the investment management entities:

• The acquirers do not belong to Apollo Hospitals' promoter or promoter group
• They operate as discretionary fund managers for various funds and segregated mandates
• The disclosure was signed by Vivian Leung, Head of Compliance, Hong Kong, on 26 January 2026

Regulatory Compliance

The filing was submitted to both the National Stock Exchange of India Ltd and The Bombay Stock Exchange Limited, where Apollo Hospitals Enterprise Ltd shares are listed. The disclosure follows SEBI regulations requiring substantial shareholders to report changes in their holdings when they cross certain thresholds.

The equity share capital and total voting capital of Apollo Hospitals Enterprise Ltd remained unchanged at 4,301,211 shares both before and after the transaction, with the diluted share capital also maintaining the same figure.

Apollo Hospitals Enterprise has received regulatory approval to acquire an additional stake in one of its key subsidiaries, marking a strategic move to strengthen its position in the wellness sector.

Regulatory Approval Details

The healthcare major has obtained permission to purchase an additional 30.58% stake in Apollo Health And Lifestyle, its subsidiary that operates in the health and wellness segment. This acquisition will significantly increase Apollo Hospitals' ownership and operational control over the subsidiary.

Strategic Implications

The acquisition of this additional stake represents Apollo Hospitals' commitment to expanding its presence in the health and lifestyle segment. Apollo Health And Lifestyle focuses on wellness services, which complements the parent company's core hospital and healthcare operations.

This move aligns with the broader trend of healthcare companies diversifying their service offerings beyond traditional medical care to include preventive health and wellness solutions. The increased ownership will likely provide Apollo Hospitals with greater strategic control over the subsidiary's operations and future direction.

Business Integration Benefits

With enhanced control over Apollo Health And Lifestyle, the parent company can better integrate wellness services with its existing healthcare infrastructure. This integration could potentially create synergies across the Apollo healthcare ecosystem, offering patients a more comprehensive range of services from preventive care to specialized medical treatments.

The regulatory approval demonstrates the authorities' confidence in Apollo Hospitals' expansion strategy and its ability to effectively manage increased stakes in its subsidiary operations.